Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1654
| Despition | ATXN3 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1106 | Recombinant Human c-Kit Protein (6×His Tag) (AC1106) | 50 µg | inquiry |
| ACPP-1370 | EFEMP1 Blocking Peptide (AC1370) | 250 µg | inquiry |
| ACPP-1400 | ACTH (AC1400) | 2 mg | inquiry |
| ACPP-1810 | Rat LIF Protein (AC1810) | 2 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1350 | Presenilin 2 Blocking Peptide (AC1350) | 250 µg | inquiry |
| ACPP-1292 | Nkx2.2 Blocking Peptide (AC1292) | 250 µg | inquiry |
| ACPP-1698 | Rat GDNF Protein (AC1698) | 2 µg | inquiry |
| ACPP-1621 | Human LZIC Protein (AC1621) | 5 µg | inquiry |
| ACPP-1578 | Human QPCT Protein (AC1578) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.